Watch Ticker

Curis Inc

Go to Curis Inc Website

$1.64

0.04 (2.50%)
Live
Previous Close

$1.67

Day Range

$1.56 - $1.72

Previous Day Range

$1.55 - $1.6562

Market Cap

$19.2 million USD

Day Vol.

62661

Previous Day Vol.

112887

Currency

USD

Primary Exchange

Nasdaq

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hem...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

Biotechnology company Curis reported a narrowed Q2 2025 net loss of $0.68 per share, beating analyst expectations. The company continues advancing its cancer therapy emavusertib while facing near-term funding challenges, with cash reserves expected to last only into Q1 2026.

Related tickers: CRIS, RHHBY.

Read Full Article

VISTA inhibitors are an emerging class of immunotherapeutic agents with significant potential in treating cancer and autoimmune diseases. Several companies are actively pursuing VISTA inhibitors, which offer a novel mechanism of action and broad applicability, but also face challenges such as complex development landscape and competition from existing therapies.

Related tickers: CRIS, KA, MRK, SNSE.

Read Full Article
Trending Tickers

Please sign in to view